查詢結果分析
來源資料
相關文獻
- Clinical Characteristic of Parenteral Iron Supplementation in Hemodialysis Patients Receiving Erythropoietin Therapy
- The Significance of Syphilis Serology Tests on Long-Term Hemodialysis Patients
- 花蓮地區長期接受血液透析患者對於疾病與治療的知識、態度及自我照顧行為相關性之研究
- 血管通路之評估--鹽液稀釋法
- 血液透析患者營養狀態主觀的總體評估(SGA)之應用
- 血液透析病人的高血壓一定合併高死亡率嗎﹖
- The Initial Status and Outcomes of Newly Diagnosed Uremic Patients in Southern Taiwan
- 血液透析療法應用於犬尿毒症之臨床病例報告
- 尿毒症患者對接受血液透析治療之認知與態度及其影響因素
- Hypermagnesemia in Chronic Dialysis Patients: Influence of Diabetic Nephropathy and Relation to Serum Albumin Concentration
頁籤選單縮合
題 名 | Clinical Characteristic of Parenteral Iron Supplementation in Hemodialysis Patients Receiving Erythropoietin Therapy=靜脈鐵劑補充對接受紅血球生成素之血液透析病患貧血臨床的表現 |
---|---|
作 者 | 高皓璽; 陳國書; 蔡啟仁; 李進昌; 張弘育; | 書刊名 | 長庚醫學 |
卷 期 | 23:10 2000.10[民89.10] |
頁 次 | 頁608-613 |
分類號 | 415.816 |
關鍵詞 | 紅血球生長素; 儲存鐵; 血液透析; 尿毒症; 靜脈鐵劑; Erythropoietin; Ferritin; Hemodialysis; HD; Uremia; Ferric saccharate; |
語 文 | 英文(English) |
英文摘要 | Background. Iron deficiency constitutes the major cause of erythropoietin hyporesponse in uremic patients receiving erythropoietin therapy; therefore, iron supplementation is necessary for these patients. Recent data suggested that intravenous iron supply is a preferable route for iron supplementation. However, it remains unclear whether a single large dose or multiple small doses are a better way of administering an intravenous iron supply. Methods. To determine the effect of different dosing schedules of intravenous iron therapy on the hematocrit level, we randomly assigned 18 patients to 3 groups. The first group of patients (n = 6) received a single dose of 800 mg intravenous fesin (ferric saccharate). The second group of patients (n = 6) received 400 mg intravenous fesin once weekly for 2 successive weeks. The third group of patients (n = 6) received 120 mg of intravenous fesin for 7 successive hemodialysis sessions. EPO was given at a fixed dose for all individuals in the study period. Results. The results showed that all 3 groups of patients had a progressive increase in hematocrit (Hct) level following intravenous iron therapy. Serum ferritin levels increased rapidly following iron therapy and then declined gradually in all 3 groups. But no statistical significance could be found among the 3 groups because of the small patient number. Also, no differences were observed in Hct or serum ferritin levels among these 3 groups of patients at all stages. Conclusion. In this study, we found that a large single dose as well as small multiple doses of parenteral iron therapy had similar effects in correcting the iron deficiency in hemodialysis patients treated with erythropoietin. To save manpower and costs, we recommend the large single dosing schedule. |
本系統中英文摘要資訊取自各篇刊載內容。